Warning letterFDA · Feb 6, 2018
Reishi D. International, Inc. MARCS-CMS 537352, February 06, 2018
Named company: Reishi D. International, Inc.
The inspection revealed serious violations of the Current Good Manufacturing Practice (cGMP) regulations for Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements Regulation…
Lot information: not specified in this record.